Latest by Katherine Moriarty
Treatment Cascade Researchers Make Case for HIV Care as Secondary Prevention for Both Sexual and Drug Behavior
Mining a decade of research for a webinar for the National Center for Innovation in HIV Care (NCIHC), Dr. Edward Gardner asserted that engagement across the HIV care continuum was associated with a reduction in HIV risk behaviors.
Not only is pre-exposure prophylaxis (PrEP) safe and effective in reducing the risk of HIV acquisition among populations at high risk of infection, it is also relatively easy to incorporate into a busy clinical practice. Here's how.
While the new meta-analysis of observational cohorts indicates an elevated risk of HIV acquisition, the implications for contraception policy or individual use are less clear.
New paper alleges that the International Monetary Fund (IMF) contributed to the circumstances that enabled the crisis to arise. The IMF says the analysis is flawed, and that it has contributed to Ebola efforts and is seeking to provide more debt reli...
People living with HIV may lose more years of life through smoking than through HIV, according to a study which found that the life expectancy of HIV-positive smokers was on average eight years less than that of nonsmokers.
Consistent condom use during anal sex prevented 70% of HIV infections among men who have sex with men, the study found -- but only 16% reported "always" using them, and "sometimes" appeared as effective at HIV prevention as "never."
A study -- based on CDC data -- recommends increased investment at each step of the care continuum, from diagnosis to viral suppression, but cautions that racial disparities in HIV transmission would likely persist for decades.
How Can AIDS Service Organizations Diversify Funding and Reach More People Under the Affordable Care Act?
The ACA makes it possible for ASOs to work alongside traditional health care providers and receive reimbursement through public and private insurance systems.
Constituency-led global networks can share credit for many important advocacy achievements over the past three years.
"If you look at concentrations of these drugs at the rectum versus the cervix and the vagina, you can probably get four days a week for rectal protection but, for women, you can't do that. You have to really go for daily dosing."